BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2023 Earnings Ca

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2023 Earnings Call Transcript November 14, 2023 BioXcel Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.72 EPS, expectations were $-1.29. Operator: Good morning, and welcome to the BioXcel Therapeutics Conference Call, which will cover its alignment with the FDA on its TRANQUILITY program, provide an update on strategic […]

Related Keywords

Qatar , United States , America , Vimal Mehta , Greg Harrison , Richard Steinhart , Columbia University , Qatar Investment Authority , White House Office Of National Drug Control , Oaktree Capital Management , Qatar Investment , Oaktree Capital , White House Office , National Drug Control , Xcel Therapeutics , Hedge Funds , Their Top Stock Picks , With The Largest Foreign Reserves , Tranquility , Bimal Mehta , Financial Results , Perator Instructions , Meeting Minutes , Fda , Dr Mehta , Herapeutics ,